Skip to main content
. Author manuscript; available in PMC: 2022 Feb 7.
Published in final edited form as: Radiother Oncol. 2019 Aug 14;141:275–282. doi: 10.1016/j.radonc.2019.07.010

Fig. 3.

Fig. 3.

(a–e) Regional percent dose difference for the PTV between the delivered and the planned mean doses. 90% isodose (D90) and 10% isodose (D10) for the skeleton five sub regions: skeleton, head & neck (HN), shoulder with clavicle (SC). Spine with Sternum, and Pelvis, for all Whole Body imaging institutions 1.2, & 3 (N = 5 for each institute). (g–k) Regional percent dose differences for the CTV as compared to the PTV mean dose. Delivered doses are calculated on the basis of recorded pretreatment shifts before radiation delivery. Regional percent differences in mean dose between (f) delivered PTV and (l) delivered CTV doses from the planned PTV mean dose in the SC. spine, head and neck (HN) based on the number of patients, presented with confidence intervals.